BioTime (BTX) Reports Q4 Loss of $0.35/Share

BioTime (NYSE: BTX) reported Q4 EPS of ($0.35), versus ($0.58) reported last year. Revenue for the quarter came in at $758 thousand, versus $999 thousand reported last year.

For earnings history and earnings-related data on BioTime (BTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• SanDisk upgraded at JPMorgan after investor day; shares climb